John Blazeck

10PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersProcess control and simulationSoftware quality, processes and metricsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 03, 2026
The Pentose Phosphate Pathway in Immunotherapy.

|Feb 06, 2026
Programming T cells for Early Cancer Detection with Customized Protease-Activatable Receptors.

Hathaichanok Phuengkham, Ying Chen, Anirudh Sivakumar

|Aug 18, 2025
RNA Polymerase III Promoters Compatible with CRISPR Gene Regulation in Saccharomyces cerevisiae.

Kendreze L Holland, Ines Blancher, Marisa McKesey

|Jul 02, 2025
Dissection of the MeCP2 repressor protein enables CRISPR platform optimization via localization engineering.

Andrew Kristof, Krithika Karunakaran, Yann Ferry

|Jul 01, 2025
Generating combinatorial diversity via engineered V(D)J-like recombination in Saccharomyces cerevisiae.

Andrew P Cazier, Jaewoo Son, Sreenivas Yellayi

|Jun 12, 2025
Engineering novel CRISPRi repressors for highly efficient mammalian gene regulation.

Andrew Kristof, Krithika Karunakaran, Christopher Allen

Pageof 2

Frequent Collaborators

1 joint publications

Maria Rain Jennings

1 joint publications

Hannah Abraham

1 joint publications

Hathaichanok Phuengkham

1 joint publications

Anirudh Sivakumar